ROCKET PHARMACEUTICALS, INC. Shares Outstanding

Quick Answer

ROCKET PHARMACEUTICALS, INC. reported Shares Outstanding of 108.32 million shares for fiscal year 2025.

ROCKET PHARMACEUTICALS, INC. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 108.32M +1.8%
2024 106.45M +17.9%
2023 90.28M +14.1%
2022 79.12M +22.7%
2021 64.51M +5.8%
2020 61.00M +11.4%
2019 54.77M +21.3%
2018 45.14M +564.3%
2017 6.80M +0.7%
2016 6.75M -74.5%
2015 26.42M +2490.3%
2014 1.02M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
September 30, 2025 108.21M +18.8% +0.3%
June 30, 2025 107.88M +18.6% +1.1%
March 31, 2025 106.75M +17.8% +0.3%
December 31, 2024 106.45M +17.9% +16.8%
September 30, 2024 91.12M +1.1% +0.2%
June 30, 2024 90.96M +13.0% +0.3%
March 31, 2024 90.65M +12.7% +0.4%
December 31, 2023 90.28M +14.1% +0.2%
  • ROCKET PHARMACEUTICALS, INC. showed an increase of +1.8% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2014–2025 period, ROCKET PHARMACEUTICALS, INC.’s shares outstanding has grown by 10518.7% (from 1.02 million shares to 108.32 million shares).
  • The most recent figure is from ROCKET PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment